project id: TCGA-KIRP; case submitter id: TCGA-B1-A654; analyte type: DNA; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.27; rna integrity number: 7.9; age at index: 43; days to birth: -15721; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1969; age at diagnosis: 15721; ajcc clinical m: M0; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 616.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 163; initial weight: 350.0; sample id: 3efddac6-ef26-4557-97ca-353024aa492d; sample submitter id: TCGA-B1-A654-01A; portion id: e2c8b408-cb41-4514-ac2c-e2596e04d8b8; portion submitter id: TCGA-B1-A654-01A-11; slide id: 4ac409bc-c454-4c63-8dcf-9c2be8d66dc3; slide submitter id: TCGA-B1-A654-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 95.0; section location: TOP;